Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Viavi Solutions Inc. Common Stock (VIAV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Viavi Solutions Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B), while Viavi Solutions Inc. Common Stock trades at $45.46 (market cap $10.85B). The key difference: Viavi Solutions Inc. Common Stock is far larger — about 6.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Viavi Solutions Inc. Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| NUVB | VIAV | |
|---|---|---|
Market Cap | $1.74B | $10.85B |
Volume | 9,289,619 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $9.54 | $55.33 |
52-Week Low | $3.41 | $12.27 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.33B | $10.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Viavi Solutions Inc. Common Stock
Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →
